查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2056888

全球組織工程市場

Tissue Engineering
出版日期: | 出版商: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 英文 123 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計2032年，全球組織工程市場規模將達332億美元。

全球組織工程市場規模預計在2025年為134億美元，在2025年至2032年的分析期內將以13.8%的複合年成長率成長，到2032年達到332億美元。本報告分析的細分市場之一——「整形外科、肌肉骨骼和脊椎應用」——預計在分析期結束時將達到83億美元，複合年成長率為11.7%。 「心血管應用」細分市場預計在整個分析期內將以16.5%的複合年成長率成長。

美國市場規模估計為 39 億美元，而中國市場預計將以 13.3% 的複合年成長率成長。

預計2025年，美國組織工程市場規模將達39億美元。作為世界第二大經濟體，中國預計在2025年至2032年的分析期間將以13.3%的複合年成長率成長，到2032年市場規模將達到58億美元。其他值得關注的區域市場包括日本和加拿大，預計在分析期內將分別以12.6%和12.3%的複合年成長率成長。在歐洲，德國預計將以約10.5%的複合年成長率成長。

全球組織工程市場—關鍵趨勢與促進因素概述

組織工程如何重新定義再生醫學？

組織工程是一門融合生物學、材料科學和工程學原理的前沿領域，旨在建立人工組織和器官。這些組織利用生物相容性支架、活細胞和生化因子進行構建，以再生受損組織並改善器官功能。組織工程在治療嚴重燒燙傷、心血管疾病、器官衰竭和肌肉骨骼損傷等方面有著廣泛的應用，它為器官移植提供了一種替代方案，從而革新了醫學。這種創新方法降低了器官排斥的風險，並縮短了移植等待時間，代表再生醫學領域的重大突破。

組織工程市場的主要細分領域有哪些？

組織工程的主要材料包括合成材料、生物來源材料和複合材料。其中，合成材料因其可控的性能、易得性和低成本而佔據較大的市場佔有率。組織工程的應用領域涵蓋整形外科、心臟病學、皮膚病學和神經病學，其中以整形外科應用最為廣泛。整形外科對人工韌帶、肌腱和軟骨的需求量龐大，這些材料能夠改善關節和骨骼疾病患者的活動能力和生活品質。組織工程的終端使用者包括醫院、研究機構和專科診所。醫院是市場的主要驅動力，主要將人工組織應用於重組手術、燒燙傷治療和器官移植。研究機構積極致力於開發用於臨床的新型組織，透過在皮膚、軟骨和心臟瓣膜的生物工程創新來推動該領域的發展。專科診所則將組織工程解決方案應用於臉部重組和皮膚移植等美容和重組手術，以改善美觀效果和促進功能恢復。

組織工程在現代醫學中是如何應用的？

在醫院，組織工程技術正被應用於重組手術，用於再生皮膚、骨骼和肌肉，尤其是在燒燙傷患者和事故倖存者中。在整形外科，組織工程軟骨和肌腱在關節修復和活動能力恢復方面取得了更好的治療效果。在心臟病學領域，研究人員正在開發組織工程心臟瓣膜和血管，旨在無需依賴捐贈器官即可治療心血管疾病。在皮膚病學領域，組織工程皮膚正被用於慢性傷口管理和美容手術，以縮短恢復時間並減少疤痕。先進支架材料和生物反應器的應用正在加速組織工程產品在各個醫學專科領域的開發和應用。

哪些因素推動了組織工程市場的成長？

組織工程市場的成長受多種因素驅動，包括器官移植需求的不斷成長、生物材料的進步以及再生醫學研究經費的增加。 3D生物列印、生物活性支架和幹細胞整合等創新技術正在推動組織工程更廣泛的應用，並擴大其在臨床領域的應用範圍。由於組織工程為慢性疾病和創傷提供了極具前景的解決方案，縮短器官移植等待時間、降低排異風險和改善患者預後的趨勢進一步推動了市場需求。此外，不斷上漲的醫療成本、有利的法規結構以及人們對先進治療方案日益成長的認知，也促進了市場成長，並加速了組織工程在全球醫療系統中的應用。

部分：

應用領域（整形外科、肌肉骨骼/脊椎、心血管、臍帶血/細胞庫、癌症、胃腸病學/婦科及其他應用）

大公司

  • Acelity LP Inc.
  • Advanced Cell Technology
  • Allergan Plc
  • Arteriocyte
  • Athersys
  • Baxter International Inc
  • BioMimetic Therapeutics
  • Cook Biotech Inc.
  • CryoLife
  • DePuy Synthes（Johnson &Johnson Services, Inc.）
  • Integra Life Sciences Corporation
  • LifeCell Kinetic Concepts
  • Medtronic
  • Organogenesis Inc.
  • RTI surgical
  • Sanofi
  • StemCells, Inc.
  • Stryker Corporation
  • Zimmer Biomet

目錄

第1章：調查方法

第2章執行摘要

  • 市場概覽
  • 大公司
  • 市場趨勢和促進因素
  • 全球市場展望

第3章 市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 世界其他地區

第4章 競賽

簡介目錄
Product Code: MCP22955

Global Tissue Engineering Market to Reach US$33.2 Billion by 2032

The global market for Tissue Engineering estimated at US$13.4 Billion in the year 2025, is expected to reach US$33.2 Billion by 2032, growing at a CAGR of 13.8% over the analysis period 2025-2032. Orthopedics, Musculoskeletal & Spine Application, one of the segments analyzed in the report, is expected to record a 11.7% CAGR and reach US$8.3 Billion by the end of the analysis period. Growth in the Cardiology & Vascular Application segment is estimated at 16.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.9 Billion While China is Forecast to Grow at 13.3% CAGR

The Tissue Engineering market in the U.S. is estimated at US$3.9 Billion in the year 2025. China, the world's second largest economy, is forecast to reach a projected market size of US$5.8 Billion by the year 2032 trailing a CAGR of 13.3% over the analysis period 2025-2032. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 12.6% and 12.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 10.5% CAGR.

Global Tissue Engineering Market - Key Trends and Drivers Summarized

How Is Tissue Engineering Redefining Regenerative Medicine?

Tissue engineering is a cutting-edge field that combines the principles of biology, materials science, and engineering to create artificial tissues or organs. These tissues are developed using biocompatible scaffolds, living cells, and biochemical factors to regenerate damaged tissues and improve organ function. Tissue engineering has found extensive applications in the treatment of severe burns, cardiovascular diseases, organ failures, and musculoskeletal injuries, transforming healthcare by providing alternatives to donor transplants. This innovative approach also reduces the risks of organ rejection and eliminates long waiting times for transplants, marking a significant leap in regenerative medicine.

What Are the Key Segments in the Tissue Engineering Market?

The key materials used in tissue engineering include synthetic materials, biologically derived materials, and composite materials. Among these, synthetic materials hold a significant share due to their controlled properties, availability, and lower costs. Applications of tissue engineering cover orthopedics, cardiology, dermatology, and neurology, with orthopedics representing the largest segment. The high demand in orthopedics is driven by the need for artificial ligaments, tendons, and cartilage, improving mobility and quality of life for patients with joint and bone disorders. End-users of tissue engineering include hospitals, research institutions, and specialty clinics. Hospitals lead the market, primarily using engineered tissues in reconstructive surgeries, burn treatments, and organ replacements. Research institutions are actively involved in developing new tissues for clinical applications, advancing the field with innovations like bioengineered skin, cartilage, and heart valves. Specialty clinics employ tissue-engineered solutions for cosmetic and reconstructive procedures, such as facial reconstruction and skin grafting, enhancing aesthetic outcomes and functional recovery.

How Is Tissue Engineering Applied in Modern Healthcare?

In hospitals, tissue engineering is used in reconstructive surgeries to regenerate skin, bones, and muscles, especially for burn victims and accident survivors. In orthopedics, tissue-engineered cartilage and tendons offer better outcomes for joint repair and mobility restoration. In cardiology, researchers are developing tissue-engineered heart valves and blood vessels, aiming to treat cardiovascular diseases without the need for donor organs. In dermatology, tissue-engineered skin is used for chronic wound management and cosmetic surgeries, offering improved recovery times and reduced scarring. The use of advanced scaffolds and bioreactors has accelerated the development and application of tissue-engineered products across different medical specialties.

What Factors Are Driving the Growth in the Tissue Engineering Market?

The growth in the Tissue Engineering market is driven by several factors, including increasing demand for organ transplants, advancements in biomaterials, and growing research funding in regenerative medicine. Innovations like 3D bioprinting, bioactive scaffolds, and stem cell integration have supported broader applications, expanding the scope of tissue engineering in clinical settings. The focus on reducing organ transplant wait times, minimizing rejection risks, and improving patient outcomes has further fueled demand, as tissue engineering offers promising solutions for chronic diseases and injuries. Additionally, rising healthcare expenditure, supportive regulatory frameworks, and increasing awareness of advanced treatment options have contributed to market growth, encouraging adoption across healthcare systems globally.

SCOPE OF STUDY:

The report analyzes the Tissue Engineering market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Application (Orthopedics, Musculoskeletal & Spine, Cardiology & Vascular, Cord Blood & Cell Banking, Cancer, Gastrointestinal & Gynecology, Other Applications)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

SELECT PLAYERS -

  • Acelity L.P. Inc.
  • Advanced Cell Technology
  • Allergan Plc
  • Arteriocyte
  • Athersys
  • Baxter International Inc
  • BioMimetic Therapeutics
  • Cook Biotech Inc.
  • CryoLife
  • DePuy Synthes (Johnson & Johnson Services, Inc.)
  • Integra Life Sciences Corporation
  • LifeCell Kinetic Concepts
  • Medtronic
  • Organogenesis Inc.
  • RTI surgical
  • Sanofi
  • StemCells, Inc.
  • Stryker Corporation
  • Zimmer Biomet

WHAT SETS THIS REPORT APART FROM OTHERS?

Validated Sources - Human-curated validation and ranking of original source content, not AI LLM-generated synthetic content which dominates the internet today and has become a quick fix for most published research reports these days. Unlike most other published sources, our customers have access to full-stack source content. Our report draws from "real intelligence" balancing the power of AI against the risks of synthetically generated content and resulting biases. Customers have access to the source feeds.

Domain Expert Insights - Domain expert insights curated from enterprise, industry, academia, and government, consolidated from multilingual multimedia formats of text, voice, and images comprise a significant resource. Customers can request access to the pool of domain experts we track for this research project. We track 43 domain experts and their insights as part of this research project. Our customers may access our online tracker.

Annual subscription - Recommended for maximum value for your research dollar. Provides one additional full update during the 12 months and access to our research portal and interactive 10-user peer-to-peer collaboration drawing from our entire stack of validated project data which is updated on a weekly basis. Platform also enables adding enterprise data or third-party licensed content to build bespoke versions. Includes competitor tracking of up to 50 companies featured in the report.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
    • How Trump's Tariffs Impact the Market? The Big Question on Everyone's Mind
    • Global Economic Update
    • Tissue Engineering - Global Key Competitors Percentage Market Share in 2026 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2026 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Use of Regenerative Medicine Drives Demand
    • Advancements in 3D Bioprinting Propel Tissue Engineering Applications
    • Rising Demand for Organ Transplants Spurs Growth Opportunities
    • Focus on Developing Artificial Organs Strengthens Business Case
    • Increasing Use of Stem Cells in Tissue Engineering Propels Adoption
    • Focus on Minimizing Rejection Risks Generates Opportunities
    • Advancements in Scaffolding Technologies Propel Innovation
    • Rising Demand for Tissue Regeneration in Orthopedic Applications Drives Adoption
    • Focus on Developing Synthetic Tissue Alternatives Expands Market Scope
    • Increasing Need for Skin Substitutes in Burn Care Generates Demand
    • Growing Use of Tissue Engineering in Drug Discovery Propels Growth
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Tissue Engineering by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 2: World 8-Year Perspective for Tissue Engineering by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2026 & 2032
    • TABLE 3: World Recent Past, Current & Future Analysis for Orthopedics, Musculoskeletal & Spine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 4: World 8-Year Perspective for Orthopedics, Musculoskeletal & Spine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2026 & 2032
    • TABLE 5: World Recent Past, Current & Future Analysis for Cardiology & Vascular by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 6: World 8-Year Perspective for Cardiology & Vascular by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2026 & 2032
    • TABLE 7: World Recent Past, Current & Future Analysis for Cord Blood & Cell Banking by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 8: World 8-Year Perspective for Cord Blood & Cell Banking by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2026 & 2032
    • TABLE 9: World Recent Past, Current & Future Analysis for Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 10: World 8-Year Perspective for Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2026 & 2032
    • TABLE 11: World Recent Past, Current & Future Analysis for Gastrointestinal & Gynecology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 12: World 8-Year Perspective for Gastrointestinal & Gynecology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2026 & 2032
    • TABLE 13: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 14: World 8-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2026 & 2032
    • TABLE 15: World Tissue Engineering Market Analysis of Annual Sales in US$ Million for Years 2020 through 2032

III. MARKET ANALYSIS

  • UNITED STATES
    • Tissue Engineering Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2026 (E)
    • TABLE 16: USA Recent Past, Current & Future Analysis for Tissue Engineering by Application - Orthopedics, Musculoskeletal & Spine, Cardiology & Vascular, Cord Blood & Cell Banking, Cancer, Gastrointestinal & Gynecology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 17: USA 8-Year Perspective for Tissue Engineering by Application - Percentage Breakdown of Value Sales for Orthopedics, Musculoskeletal & Spine, Cardiology & Vascular, Cord Blood & Cell Banking, Cancer, Gastrointestinal & Gynecology and Other Applications for the Years 2026 & 2032
  • CANADA
    • TABLE 18: Canada Recent Past, Current & Future Analysis for Tissue Engineering by Application - Orthopedics, Musculoskeletal & Spine, Cardiology & Vascular, Cord Blood & Cell Banking, Cancer, Gastrointestinal & Gynecology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 19: Canada 8-Year Perspective for Tissue Engineering by Application - Percentage Breakdown of Value Sales for Orthopedics, Musculoskeletal & Spine, Cardiology & Vascular, Cord Blood & Cell Banking, Cancer, Gastrointestinal & Gynecology and Other Applications for the Years 2026 & 2032
  • JAPAN
    • Tissue Engineering Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2026 (E)
    • TABLE 20: Japan Recent Past, Current & Future Analysis for Tissue Engineering by Application - Orthopedics, Musculoskeletal & Spine, Cardiology & Vascular, Cord Blood & Cell Banking, Cancer, Gastrointestinal & Gynecology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 21: Japan 8-Year Perspective for Tissue Engineering by Application - Percentage Breakdown of Value Sales for Orthopedics, Musculoskeletal & Spine, Cardiology & Vascular, Cord Blood & Cell Banking, Cancer, Gastrointestinal & Gynecology and Other Applications for the Years 2026 & 2032
  • CHINA
    • Tissue Engineering Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2026 (E)
    • TABLE 22: China Recent Past, Current & Future Analysis for Tissue Engineering by Application - Orthopedics, Musculoskeletal & Spine, Cardiology & Vascular, Cord Blood & Cell Banking, Cancer, Gastrointestinal & Gynecology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 23: China 8-Year Perspective for Tissue Engineering by Application - Percentage Breakdown of Value Sales for Orthopedics, Musculoskeletal & Spine, Cardiology & Vascular, Cord Blood & Cell Banking, Cancer, Gastrointestinal & Gynecology and Other Applications for the Years 2026 & 2032
  • EUROPE
    • Tissue Engineering Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2026 (E)
    • TABLE 24: Europe Recent Past, Current & Future Analysis for Tissue Engineering by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 25: Europe 8-Year Perspective for Tissue Engineering by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2026 & 2032
    • TABLE 26: Europe Recent Past, Current & Future Analysis for Tissue Engineering by Application - Orthopedics, Musculoskeletal & Spine, Cardiology & Vascular, Cord Blood & Cell Banking, Cancer, Gastrointestinal & Gynecology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 27: Europe 8-Year Perspective for Tissue Engineering by Application - Percentage Breakdown of Value Sales for Orthopedics, Musculoskeletal & Spine, Cardiology & Vascular, Cord Blood & Cell Banking, Cancer, Gastrointestinal & Gynecology and Other Applications for the Years 2026 & 2032
  • FRANCE
    • Tissue Engineering Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2026 (E)
    • TABLE 28: France Recent Past, Current & Future Analysis for Tissue Engineering by Application - Orthopedics, Musculoskeletal & Spine, Cardiology & Vascular, Cord Blood & Cell Banking, Cancer, Gastrointestinal & Gynecology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 29: France 8-Year Perspective for Tissue Engineering by Application - Percentage Breakdown of Value Sales for Orthopedics, Musculoskeletal & Spine, Cardiology & Vascular, Cord Blood & Cell Banking, Cancer, Gastrointestinal & Gynecology and Other Applications for the Years 2026 & 2032
  • GERMANY
    • Tissue Engineering Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2026 (E)
    • TABLE 30: Germany Recent Past, Current & Future Analysis for Tissue Engineering by Application - Orthopedics, Musculoskeletal & Spine, Cardiology & Vascular, Cord Blood & Cell Banking, Cancer, Gastrointestinal & Gynecology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 31: Germany 8-Year Perspective for Tissue Engineering by Application - Percentage Breakdown of Value Sales for Orthopedics, Musculoskeletal & Spine, Cardiology & Vascular, Cord Blood & Cell Banking, Cancer, Gastrointestinal & Gynecology and Other Applications for the Years 2026 & 2032
  • ITALY
    • TABLE 32: Italy Recent Past, Current & Future Analysis for Tissue Engineering by Application - Orthopedics, Musculoskeletal & Spine, Cardiology & Vascular, Cord Blood & Cell Banking, Cancer, Gastrointestinal & Gynecology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 33: Italy 8-Year Perspective for Tissue Engineering by Application - Percentage Breakdown of Value Sales for Orthopedics, Musculoskeletal & Spine, Cardiology & Vascular, Cord Blood & Cell Banking, Cancer, Gastrointestinal & Gynecology and Other Applications for the Years 2026 & 2032
  • UNITED KINGDOM
    • Tissue Engineering Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2026 (E)
    • TABLE 34: UK Recent Past, Current & Future Analysis for Tissue Engineering by Application - Orthopedics, Musculoskeletal & Spine, Cardiology & Vascular, Cord Blood & Cell Banking, Cancer, Gastrointestinal & Gynecology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 35: UK 8-Year Perspective for Tissue Engineering by Application - Percentage Breakdown of Value Sales for Orthopedics, Musculoskeletal & Spine, Cardiology & Vascular, Cord Blood & Cell Banking, Cancer, Gastrointestinal & Gynecology and Other Applications for the Years 2026 & 2032
  • REST OF EUROPE
    • TABLE 36: Rest of Europe Recent Past, Current & Future Analysis for Tissue Engineering by Application - Orthopedics, Musculoskeletal & Spine, Cardiology & Vascular, Cord Blood & Cell Banking, Cancer, Gastrointestinal & Gynecology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 37: Rest of Europe 8-Year Perspective for Tissue Engineering by Application - Percentage Breakdown of Value Sales for Orthopedics, Musculoskeletal & Spine, Cardiology & Vascular, Cord Blood & Cell Banking, Cancer, Gastrointestinal & Gynecology and Other Applications for the Years 2026 & 2032
  • ASIA-PACIFIC
    • Tissue Engineering Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2026 (E)
    • TABLE 38: Asia-Pacific Recent Past, Current & Future Analysis for Tissue Engineering by Application - Orthopedics, Musculoskeletal & Spine, Cardiology & Vascular, Cord Blood & Cell Banking, Cancer, Gastrointestinal & Gynecology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 39: Asia-Pacific 8-Year Perspective for Tissue Engineering by Application - Percentage Breakdown of Value Sales for Orthopedics, Musculoskeletal & Spine, Cardiology & Vascular, Cord Blood & Cell Banking, Cancer, Gastrointestinal & Gynecology and Other Applications for the Years 2026 & 2032
  • REST OF WORLD
    • TABLE 40: Rest of World Recent Past, Current & Future Analysis for Tissue Engineering by Application - Orthopedics, Musculoskeletal & Spine, Cardiology & Vascular, Cord Blood & Cell Banking, Cancer, Gastrointestinal & Gynecology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 41: Rest of World 8-Year Perspective for Tissue Engineering by Application - Percentage Breakdown of Value Sales for Orthopedics, Musculoskeletal & Spine, Cardiology & Vascular, Cord Blood & Cell Banking, Cancer, Gastrointestinal & Gynecology and Other Applications for the Years 2026 & 2032

IV. COMPETITION